- Home
- FDMT vs XOMA Comparison
FDMT vs XOMA Comparison
Compare FDMT & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FDMT
- XOMA
- Stock Information
- Founded
- FDMT 2013
- XOMA 1981
- Country
- FDMT United States
- XOMA United States
- Employees
- FDMT N/A
- XOMA N/A
- Industry
- FDMT Biotechnology: Pharmaceutical Preparations
- XOMA Biotechnology: Pharmaceutical Preparations
- Sector
- FDMT Health Care
- XOMA Health Care
- Exchange
- FDMT Nasdaq
- XOMA Nasdaq
- Market Cap
- FDMT 420.7M
- XOMA 355.6M
- IPO Year
- FDMT 2020
- XOMA N/A
- Fundamental
- Price
- FDMT $7.88
- XOMA $30.10
- Analyst Decision
- FDMT Strong Buy
- XOMA Strong Buy
- Analyst Count
- FDMT 9
- XOMA 2
- Target Price
- FDMT $46.75
- XOMA $78.50
- AVG Volume (30 Days)
- FDMT 759.8K
- XOMA 31.3K
- Earning Date
- FDMT 11-13-2024
- XOMA 11-07-2024
- Dividend Yield
- FDMT N/A
- XOMA N/A
- EPS Growth
- FDMT N/A
- XOMA N/A
- EPS
- FDMT N/A
- XOMA N/A
- Revenue
- FDMT $17,000.00
- XOMA $21,606,000.00
- Revenue This Year
- FDMT N/A
- XOMA $488.61
- Revenue Next Year
- FDMT $57.85
- XOMA $27.42
- P/E Ratio
- FDMT N/A
- XOMA N/A
- Revenue Growth
- FDMT N/A
- XOMA 389.82
- 52 Week Low
- FDMT $7.32
- XOMA $14.33
- 52 Week High
- FDMT $36.25
- XOMA $33.78
- Technical
- Relative Strength Index (RSI)
- FDMT 41.01
- XOMA 53.56
- Support Level
- FDMT $8.04
- XOMA $29.20
- Resistance Level
- FDMT $8.96
- XOMA $31.24
- Average True Range (ATR)
- FDMT 0.59
- XOMA 1.38
- MACD
- FDMT 0.16
- XOMA -0.17
- Stochastic Oscillator
- FDMT 37.10
- XOMA 29.00
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.
About XOMA XOMA Corporation
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.